Intellectual Property India Publishes Patent Application for Irna Compositions And Methods For Silencing Growth Factor Receptor Bound Protein 14 (grb14) In The Liver

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202647126003 A) filed by Alnylam Pharmaceuticals, Inc. on October 22, 2026, for Irna Compositions And Methods For Silencing Growth Factor Receptor Bound Protein 14 (grb14) In The Liver.

Inventors include Bondurant, Lucas; Mcininch, James D.; Schlegel, Mark K.; Castoreno, Adam; and Nguyen, Tuyen M..

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The disclosure relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the GRB14 gene, as well as methods of inhibiting expression of GRB14, and methods of treating subjects that would benefit from reduction in expression of GRB14, such a...